TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33904977

Group type: EXPERIMENTAL
Intervention: Open total adventitial resection of the cardia (TARC), n = 45
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Hybrid Ivor Lewis oesophagectomy (HILO), n = 50
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Laparoscopic‐thoracoscopic assisted (LTA), n = 56
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Totally minimally invasive TARC (TMI TARC), n = 47
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 198
Study: 35174901

Group type: EXPERIMENTAL
Intervention: Novel mechanical compression device (PressRite, PR)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 105
Study: 34343414

Group type: EXPERIMENTAL
Intervention: Focused Attention Meditation (FAM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Random thinking (Control)
Number of subjects: 30
Study: 34800819

Group type: EXPERIMENTAL
Intervention: OJ (orange juice containing 345 mg of hesperidin; n=15)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: EOJ (enhanced orange juice containing 600 mg of hesperidin; n=11)
Number of subjects: 37

Group type: COMPARATOR
Intervention: CD (control drink; n=11)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: EOJ
Number of subjects: 37
Study: 32633157

Group type: EXPERIMENTAL
Intervention: Everolimus with reduced calcineurin inhibitor (EVR+rCNI)
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Mycophenolic acid plus standard-exposure CNI (MPA+sCNI)
Number of subjects: 2026
Study: 35641048

Group type: EXPERIMENTAL
Intervention: Telepsychiatry collaborative care
Number of subjects: 12

Group type: COMPARATOR
Intervention: Referral approach
Number of subjects: 12
Study: 34358497

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg and lamivudine 300 mg once daily
Number of subjects: 265

Group type: COMPARATOR
Intervention: Triple ART
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Dolutegravir plus lamivudine
Number of subjects: 265
Study: 32032954

Group type: EXPERIMENTAL
Intervention: Bilateral cZi DBS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Best Medical Treatment (BMT)
Number of subjects: 25
Study: 35283398

Group type: EXPERIMENTAL
Intervention: Weight loss in the first quartile (median change -1.02 kg)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Weight loss in the second quartile (median change -0.25 kg)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Weight loss in the third quartile (median change +0.26 kg)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Weight loss in the fourth quartile (median change +0.86 kg)
Number of subjects: 404
Study: 32331737

Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Natural ointment based on honey-tea tree oil
Number of subjects: 27
Study: 36000709

Group type: EXPERIMENTAL
Intervention: Self-determination theory (SDT)‐guided dental education (three face‐to‐face educational sessions)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Conventional dental instruction (one session)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Self-determination theory (SDT)‐guided dental education
Number of subjects: 196
Study: 33665839

Group type: EXPERIMENTAL
Intervention: Standard care plus study interventions
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 123
Study: 35007787

Group type: EXPERIMENTAL
Intervention: Behavioral intervention with run-in procedures (food diary completion, questionnaire completion, staff interview)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predicted moderate adherers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predicted low adherers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Run-in data
Number of subjects: 0
Study: 33751522

Group type: EXPERIMENTAL
Intervention: Galactagogue Group (barley malt-based composition with β-glucan and lemon balm)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Galactagogue Group
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo Group
Number of subjects: 117
Study: 34789480

Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 0
Study: 34536960

Group type: EXPERIMENTAL
Intervention: Zirconia crowns (ZC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Stainless steel crowns (SSC)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Strip crowns (SC)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Parent and child satisfaction
Number of subjects: 45
Study: 34653814

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (twice endometrial sampling in follicular and luteal phases)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (only luteal phase sampling)
Number of subjects: 20
Study: 32398726

Group type: EXPERIMENTAL
Intervention: Urolithin metabotypes (UM-B or UM-0)
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Low KIDMED score
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Consortium of 24 SNPs (including rs1801253-ADRB1, rs4343-ACE, rs8061518-FTO, rs1130864-CRP, rs659366-UCP2, rs6131-SELP, rs12535708-LEP, rs1501299-ADIPOQ, rs708272-CETP, rs2241766-ADIPOQ)
Number of subjects: 415
Study: 34110861

Group type: EXPERIMENTAL
Intervention: Personalized Match System
Number of subjects: 218

Group type: COMPARATOR
Intervention: Usual assignment
Number of subjects: 218
Study: 34831644

Group type: EXPERIMENTAL
Intervention: HIV self‐testing infographic intervention
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 322
Study: 33145856

Group type: EXPERIMENTAL
Intervention: Restorations planted with species-rich seed mixes
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Higher organic matter and more linear shape
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Age of planting
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Management of exotic species
Number of subjects: 93
Study: 33327326

Group type: EXPERIMENTAL
Intervention: Peony and licorice decoction (PLD) fumigation treatment
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo fumigation treatment
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: PLD fumigation treatment
Number of subjects: 190
Study: 33906081

Group type: EXPERIMENTAL
Intervention: kMCT (30 g/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (calorie-matched)
Number of subjects: 39
Study: 33123219

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment for 12 months
Number of subjects: 118
Study: 33772749

Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral intervention (provider-focused alerts and patient-focused video)
Number of subjects: 552
Study: 32502445

Group type: EXPERIMENTAL
Intervention: Open radical hysterectomy
Number of subjects: 631

Group type: COMPARATOR
Intervention: Minimally invasive radical hysterectomy
Number of subjects: 631
Study: 34942085

Group type: EXPERIMENTAL
Intervention: Elexacaftor 200 mg orally once daily plus tezacaftor 100 mg orally once daily plus ivacaftor 150 mg orally every 12 h
Number of subjects: 176

Group type: COMPARATOR
Intervention: Tezacaftor 100 mg orally once daily plus ivacaftor 150 mg orally every 12 h
Number of subjects: 176
Study: 32282494

Group type: EXPERIMENTAL
Intervention: Auricular tenderness
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Auricular acupressure points
Number of subjects: 217
Study: 36241051

Group type: EXPERIMENTAL
Intervention: Surfactant via Laryngeal Mask Airway (LMA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Surfactant via Endotracheal Tube (ETT)
Number of subjects: 93
Study: 34077535

Group type: EXPERIMENTAL
Intervention: NRT + prescription medication
Number of subjects: 6285

Group type: EXPERIMENTAL
Intervention: Phone + In Person
Number of subjects: 6285

Group type: COMPARATOR
Intervention: Reasons for declining enrollment
Number of subjects: 6285
Study: 34580067

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: HIIT+yoga
Number of subjects: 334

Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 334
Study: 33861306

Group type: EXPERIMENTAL
Intervention: Low stable SBP trajectory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High stable SBP trajectory
Number of subjects: 0
Study: 32725447

Group type: EXPERIMENTAL
Intervention: Scapular-focused treatment with feedback (SFTF)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Scapular-focused treatment without feedback (SFT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 32045868

Group type: EXPERIMENTAL
Intervention: Video-based exergaming
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35536104

Group type: EXPERIMENTAL
Intervention: RT-compliant (RC) group
Number of subjects: 125

Group type: COMPARATOR
Intervention: Non–RT-compliant (NRC) group
Number of subjects: 125
Study: 32699034

Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg intravenous every 4 weeks
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 34913216

Group type: EXPERIMENTAL
Intervention: Paper voucher described as redeemable for free follow-up and prescription glasses
Number of subjects: 821

Group type: EXPERIMENTAL
Intervention: Paper voucher with monetary value indication ($250)
Number of subjects: 821

Group type: COMPARATOR
Intervention: Standard referral for a free follow-up appointment and prescription glasses
Number of subjects: 821
Study: 33731062

Group type: EXPERIMENTAL
Intervention: Active study product (combination of Bifidobacterium breve M‐16V, short‐chain galacto‐oligosaccharides, long‐chain fructo‐oligosaccharides and L‐glutamine)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 34750775

Group type: EXPERIMENTAL
Intervention: Implicit Sexual Risk Assessment (ISRA)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Balloon Analogue Risk Task (BART)
Number of subjects: 79

Group type: COMPARATOR
Intervention: BART and ISRA
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sexual arousal
Number of subjects: 79
Study: 33828238

Group type: EXPERIMENTAL
Intervention: Genetically predicted selenium
Number of subjects: 1000000
Study: 32023537

Group type: EXPERIMENTAL
Intervention: Home-based muscle power training intervention
Number of subjects: 12

Group type: COMPARATOR
Intervention: Step-monitoring comparison group
Number of subjects: 12
Study: 35652362

Group type: EXPERIMENTAL
Intervention: Machine-vision (MV)‐based dynamic navigation (DN)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (freehand technique)
Number of subjects: 24
Study: 36191117

Group type: EXPERIMENTAL
Intervention: SwasthGarbh App
Number of subjects: 150
Study: 34242463

Group type: EXPERIMENTAL
Intervention: Treatment Access Pathway (TAP)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 181
Study: 33428832

Group type: EXPERIMENTAL
Intervention: Face coverings
Number of subjects: 0
Study: 35292336

Group type: EXPERIMENTAL
Intervention: Holistic-thinking group with positive affect
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Analytic-thinking group with positive affect
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Analytic-thinking group with negative affect
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Holistic-thinking group with negative affect
Number of subjects: 44
Study: 33726984

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 1014

Group type: EXPERIMENTAL
Intervention: Statin users (PSM cohort)
Number of subjects: 1014

Group type: COMPARATOR
Intervention: Statin non-users (PSM cohort)
Number of subjects: 1014
Study: 32575450

Group type: EXPERIMENTAL
Intervention: Harvesting at week 16 with 1st harvest frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harvesting age (week 8, 12, and 16)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harvesting frequency (harvest 1, 2, and 3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bioactive compounds (shaftoside, iso‐orientin, and orientin)
Number of subjects: 0
Study: 33191527

Group type: EXPERIMENTAL
Intervention: Prior cycling exercise (1 hour at 70-75% V̇O2peak)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-glucose mixed-nutrient meal ingestion (1.1 g glucose/kg body weight; 45% carbohydrate, 20% protein, 35% fat)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no-exercise)
Number of subjects: 8
Study: 33271093

Group type: EXPERIMENTAL
Intervention: HPV 16/18 AS04‐adjuvanted vaccine
Number of subjects: 7466

Group type: COMPARATOR
Intervention: Control hepatitis A vaccine
Number of subjects: 7466
Study: 35587890

Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standardized Risk Assessment (SRA)
Number of subjects: 200
Study: 33150850

Group type: EXPERIMENTAL
Intervention: Home based exercise program with activity tracking device, personalized feedback, and financial incentives
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Home based exercise program with activity tracking device and personalized feedback
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group with activity monitoring device but no feedback
Number of subjects: 41
Study: 34553964

Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Standard Care (SC) + Contingency Management (CM)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 557
Study: 33433136

Group type: EXPERIMENTAL
Intervention: Initiating discussions about DNR with patients' families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initiating discussions about DNR with patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiences of actively initiating DNR discussions with patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experiences of actively initiating DNR discussions with patients' families
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjusted factors
Number of subjects: 0
Study: 36170326

Group type: EXPERIMENTAL
Intervention: Oral amino acid challenge (AAC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Isocaloric glucose solution (GS)
Number of subjects: 9
Study: 33378082

Group type: EXPERIMENTAL
Intervention: Hazardous drinking
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Moderate impulsivity
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: High impulsivity
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Impulsivity
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Hazardous drinking and impulsivity
Number of subjects: 241
Study: 34931782

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sedentary Control (CON)
Number of subjects: 14
Study: 32066431

Group type: EXPERIMENTAL
Intervention: 5° conical internal hexed connection (Anyridge®, MegaGen, South Korea)
Number of subjects: 104

Group type: COMPARATOR
Intervention: internal hexed connection (Core®, Kristal, Italy)
Number of subjects: 104
Study: 36394566

Group type: EXPERIMENTAL
Intervention: PaFein teaching model (9 hours course)
Number of subjects: 172
Study: 34470624

Group type: EXPERIMENTAL
Intervention: Enhanced measurement-based care (eMBC) using digital technologies
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Standard measurement-based care (MBC)
Number of subjects: 417
Study: 32157126

Group type: EXPERIMENTAL
Intervention: Twist tube (group T)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional tube (group C)
Number of subjects: 86
Study: 33994142

Group type: EXPERIMENTAL
Intervention: Slowness in Eating
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Satiety Responsiveness
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Enjoyment of Food
Number of subjects: 322
Study: 36116950

Group type: EXPERIMENTAL
Intervention: Milled bases (MB1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Printed bases (PB1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional bases (CB)
Number of subjects: 20
Study: 32215135

Group type: EXPERIMENTAL
Intervention: PELD combined with PEEK rod
Number of subjects: 243

Group type: COMPARATOR
Intervention: PELD
Number of subjects: 243
Study: 36301455

Group type: EXPERIMENTAL
Intervention: Jianpi Jieyu Decoction (JJD)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 140
Study: 34482187

Group type: EXPERIMENTAL
Intervention: IPS + CR
Number of subjects: 73

Group type: COMPARATOR
Intervention: IPS + Control
Number of subjects: 73
Study: 32921262

Group type: EXPERIMENTAL
Intervention: Device arm (PFO closure) in low RoPE score group (<7)
Number of subjects: 2133

Group type: COMPARATOR
Intervention: Medical arm in low RoPE score group (<7)
Number of subjects: 2133

Group type: EXPERIMENTAL
Intervention: Device arm (PFO closure) in high RoPE score group (≥7)
Number of subjects: 2133

Group type: COMPARATOR
Intervention: Medical arm in high RoPE score group (≥7)
Number of subjects: 2133

Group type: EXPERIMENTAL
Intervention: Overall analysis of RoPE score
Number of subjects: 2133
Study: 34607600

Group type: EXPERIMENTAL
Intervention: Oral immunomodulation with UTI-relevant Escherichia coli lysate (Uro-Vaxom) for 90 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 33182482

Group type: EXPERIMENTAL
Intervention: Gestational weight gain (GWG)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Gestational diabetes (GDM)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Maternal obesity
Number of subjects: 423

Group type: COMPARATOR
Intervention: Control (no GDM)
Number of subjects: 423
Study: 33616910

Group type: EXPERIMENTAL
Intervention: Two proposed tools for inference about causal effects with invalid instruments (confidence intervals and novel test for null causal effect)
Number of subjects: 0
Study: 33785557

Group type: EXPERIMENTAL
Intervention: FMT plus lifestyle intervention (LSI)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: FMT alone
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham plus LSI
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Repeated FMTs
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: FMT with LSI
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: FMT plus LSI
Number of subjects: 61
Study: 33902505

Group type: EXPERIMENTAL
Intervention: Aquatic exercise intervention (AEI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 43
Study: 35718535

Group type: EXPERIMENTAL
Intervention: Modified Yiyi Baijiang Decoction combined with external application for four weeks
Number of subjects: 130

Group type: COMPARATOR
Intervention: Acitretin Capsules and Calcipotriol Ointment
Number of subjects: 130
Study: 32930784

Group type: EXPERIMENTAL
Intervention: Mepilex® Ag
Number of subjects: 119

Group type: COMPARATOR
Intervention: Biobrane™
Number of subjects: 119
Study: 33475736

Group type: EXPERIMENTAL
Intervention: Unrelated umbilical cord blood (UCB) transplantation
Number of subjects: 368

Group type: COMPARATOR
Intervention: HLA-haploidentical bone marrow transplantation
Number of subjects: 368
Study: 32033922

Group type: EXPERIMENTAL
Intervention: LSD (13 μg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 36447332

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (BMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active comparison group (QoL)
Number of subjects: 0
Study: 34703035

Group type: EXPERIMENTAL
Intervention: Flebitis Zero project intervention
Number of subjects: 656

Group type: COMPARATOR
Intervention: Control Group (prior to intervention)
Number of subjects: 656
Study: 34109545

Group type: EXPERIMENTAL
Intervention: Coached clinics (received online toolkit plus weekly assistance from a distance coach for 12 months)
Number of subjects: 2484

Group type: COMPARATOR
Intervention: Non-coached clinics (received online toolkit with evidence-based tools and QI coaching manual)
Number of subjects: 2484

Group type: EXPERIMENTAL
Intervention: Coached clinics
Number of subjects: 2484

Group type: COMPARATOR
Intervention: Non-coached clinics
Number of subjects: 2484
Study: 33020648

Group type: EXPERIMENTAL
Intervention: Spartalizumab (400 mg every 4 weeks) + Dabrafenib (150 mg twice daily) + Trametinib (2 mg once daily)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Spartalizumab + Dabrafenib + Trametinib
Number of subjects: 36
Study: 34350657

Group type: EXPERIMENTAL
Intervention: Short wavelength bright light therapy (BLT)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Long wavelength bright light therapy (BLT)
Number of subjects: 63
Study: 34848798

Group type: EXPERIMENTAL
Intervention: Smartphone application-based provision of fertility-related information for one week
Number of subjects: 3765

Group type: COMPARATOR
Intervention: General information about women’s healthcare (Control)
Number of subjects: 3765

Group type: EXPERIMENTAL
Intervention: Smartphone application-based provision of fertility-related information
Number of subjects: 3765
Study: 32375722

Group type: EXPERIMENTAL
Intervention: Body image assessment using Fisher Body Image Questionnaire; Mean score: 163.26±20.38
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Anxiety assessment using Spielberger Anxiety Questionnaire; Mean score: 12.00±7.71
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Depression assessment using Beck Depression questionnaire; Mean score: 42.70±8.40
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Multiple linear correlation analysis; Body image as a predictor for depression and anxiety
Number of subjects: 307
Study: 35030011

Group type: EXPERIMENTAL
Intervention: Spartalizumab 400 mg intravenously every 4 weeks plus dabrafenib 150 mg orally twice daily and trametinib 2 mg orally once daily
Number of subjects: 532

Group type: COMPARATOR
Intervention: Placebo plus dabrafenib 150 mg orally twice daily and trametinib 2 mg orally once daily
Number of subjects: 532
Study: 34242108

Group type: EXPERIMENTAL
Intervention: Roll Stability Control (RSC) fitment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-fitment of Roll Stability Control (RSC)
Number of subjects: 0
Study: 32696895

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) with antidepressants
Number of subjects: 24

Group type: COMPARATOR
Intervention: Antidepressants only (Control)
Number of subjects: 24